Ironwood shareholders opt to keep board intact

Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) said its shareholders re-elected all three of its preferred board director nominees during its annual shareholder meeting. Alex Denner, who holds about a 2.2% stake in Ironwood and is chief investment officer at

Read the full 375 word article

How to gain access

Continue reading with a
two-week free trial.